T/FIF, a New Plateau Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: The Dodgy Ticker who wrote (492)	5/23/2001 2:30:48 PM
From: keokalani'nui	Read Replies (1) of 2243

Robert, just to add something to: >>Wilder liked the OXGN ASCO data<< I just posted the abstract, which I bumped into. Though it does look positive considering its limited scope, my opinion on it--thanks anyway--is honestly not worth much. Really. Incidentally, and perhaps as evidence for my demeure, when I first looked at Techniclone 2 years ago, I thought it was headed for the ash heap. I'm still trying to sort out how it stayed and stays alive and whether I should laugh or cry for oxgn. But if you believe in the future VTAs (combretastatin is not owned by the JV), there is certainly what one poster calls 'leverage' in owning tecniclone. Luck to ya, I hope it shoots the moon. Wilder

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next